| Literature DB >> 9147379 |
G P Ahern1, P R Junankar, A F Dulhunty.
Abstract
In this report we demonstrate that the immunosuppressive drug, rapamycin, can reversibly activate the skeletal muscle ryanodine receptor calcium release channel (RyR) in terminal cisternae vesicles incorporated into planar lipid bilayers. This reveals a second mechanism of activation of RyRs by rapamycin. Irreversible channel activation and openings to subconductance levels are seen when rapamycin forms a complex with and removes the tightly bound 12 kDa FK506-binding protein (FKBP12) from the RyR. We show here that micromolar rapamycin activates RyRs which were previously 'stripped' of > 95% of their FKBP12s. Rapamycin caused a 6-fold increase in mean current, which was largely reversible, but no increase in the fraction of openings to subconductance levels. Therefore native RyRs, stripped of FKBP12, are directly activated by the macrocyclic lactone, rapamycin.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9147379 DOI: 10.1016/s0304-3940(97)00193-6
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046